You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. STTR Phase I: Protease-based purification of recombinant human matrix metalloproteases

    SBC: Sarkar-Klein-Labs            Topic: BT

    The broader impact of this Small Business Technology Transfer (STTR) Phase I project is an enabling technology to improve research into many diseases. This STTR project will develop human matrix metalloprotease (MMPs), a class of enzymes that degrade many biomolecules including collagen, the most abundant structural protein in the human body. MMPs are critical for numerous normal and pathological ...

    STTR Phase I 2021 National Science Foundation
  2. STTR Phase I: Design and development of novel oral drug formulations by leveraging the food effect

    SBC: MECHASIM INC.            Topic: PT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is the development of novel food-based oral dosage forms of pharmaceutics potentially superior to traditional tablets as they can be administered at lower doses without compromising therapeutic benefits. Currently tablet form preparations require administration at high doses to achieve desired ...

    STTR Phase I 2021 National Science Foundation
  3. STTR Phase I: A kinetic and conformation based platform for targeting G-protein coupled receptors

    SBC: Seven Biosciences, Inc.            Topic: PT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to enable the discovery of new therapeutics targeting G protein-coupled receptors (GCPRs). GPCRs are expressed in nearly every organ system, are accessible due to their location on the membrane and potential to elicit almost every signaling pathway. Drugs targeting GPCRs make up 35% of all ...

    STTR Phase I 2021 National Science Foundation
  4. STTR Phase I: A Pair of Linked Cartographic Maps of our Brain Derived from Clinical Glaucoma Data

    SBC: Gautam Thor            Topic: DH

    The broader impact commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to improve the accessibility of eye health care. Glaucoma is a major cause of irreversible blindness but can be addressed with early detection, and the prevalence increases with age. However, existing tests can be tiring and difficult and require specialized equipment. This project will adv ...

    STTR Phase I 2021 National Science Foundation
  5. STTR Phase I: Microbial Discovery and Biosynthesis of Targeted Protease Inhibitors (COVID-19)

    SBC: THINK BIOSCIENCE, INC.            Topic: PT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase 1 project is to develop new lead compounds for treating COVID-19 by using microbial systems. The microbial assembly approach, which enables rapid, fermentation-based scale-up of therapeutic candidates for pre-clinical studies and early human trials, could accelerate the pace and reduce the cost of thera ...

    STTR Phase I 2021 National Science Foundation
  6. STTR Phase I: Smart IoT Wearable for Remote Monitoring and Assessment of COVID-19 Patients (COVID-19)

    SBC: Lasarrus Clinic and Research Center            Topic: DH

    The broader impact /commercial potential of this Small Business Technology Transfer (STTR) Phase I project will help COVID-19 patients with a lower burden to the medical system. This project will lead to a low-cost wearable internet of things (IoT) system to enable improved telemedicine. The collected data can be leveraged for public health purposes. The proposed project will develop telemedicine ...

    STTR Phase I 2021 National Science Foundation
  7. STTR Phase I: Nanoparticulate metal oxide electrodes for fast charging lithium ion batteries

    SBC: Battery Streak, Inc.            Topic: EN

    The broader impact/commercial potential of this project is to develop and commercialize a fast charging battery which offers better safety with long cycle life compared to today’s lithium (Li)-ion batteries. In traditional batteries, fast charging can cause the battery to become dangerously hot (more than 60°C/140°F) and reduce the life of the battery to one or two charges. The proposed batter ...

    STTR Phase I 2021 National Science Foundation
  8. STTR Phase I: Feasibility Study of Chip-Scale Iodine Vapor Cell Fabrication

    SBC: VAPOR CELL TECHNOLOGIES LLC            Topic: IH

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to improve measurement science. Currently, special low-pressure chambers known as "vapor cells" are made by hand in a select number of precision glassblowing shops and suffer from poor dimensional reproducibility, low production capacity, irregular sizes, and variable vapor composition lead ...

    STTR Phase I 2021 National Science Foundation
  9. STTR Phase I: Probabilistic and Explainable Deep Learning for the Intuitive Predictive Maintenance of Industrial and Agricultural Equipment

    SBC: Percev LLC            Topic: I

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project proposes a deep learning approach to predictive maintenance of industrial and agricultural equipment. High productivity demands and just-in-time approaches to manufacturing mean that equipment downtime can be extremely expensive; Research shows that the average manufacturer deals with 800 hour ...

    STTR Phase I 2021 National Science Foundation
  10. STTR Phase I: A platform for the rapid discovery of human antibodies as therapeutics for infectious disease (COVID-19)

    SBC: Altigg Therapeutics, Inc.            Topic: PT

    The broader impacts of this Small Business Technology Transfer (STTR) Phase I project are to establish a novel and rapid drug-discovery platform aimed at infectious diseases. An opportunity is to tap into an unexplored diversity of human antibodies and develop them into therapies. This technology aims to identify drug candidates and select therapeutic candidates quickly. The established platform w ...

    STTR Phase I 2021 National Science Foundation
US Flag An Official Website of the United States Government